Current Status of COVID-19 Vaccines Rollout Nationwide: March 2022 Update for the Attorney General Community

On March 24, the U.S. reached 255.1 million persons (76.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 217.3 million persons (65.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: February 2022 Update for the Attorney General Community

On February 18, the U.S. reached 252.5 million persons (76.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 214.5 million persons (64.6% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Crisis Standards of Care During the COVID-19 Pandemic: Legal and Policy-Related Issues

As various regions of the the United States experienced COVID-19-related surges in cases, hospitals and other providers have reported scarcity in essential resources (e.g., available intensive care unit (ICU) beds, personnel, treatments, and personal protective equipment (PPE)). In response, providers as well as state, territorial, and local health authorities have prepared and/or implemented crisis standards…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: January 2022 Update for the Attorney General Community

On January 18, the U.S. reached 249.4 million persons (75.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 209.3 million persons (63.0% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

NAAG Responds to FDA’s Comment Request on New Over-The-Counter Hearing Aid Rules

In response to a request for comments from the Food and Drug Administration (FDA) regarding new rules regulating over-the-counter hearing aids, NAAG submitted comments encouraging the FDA to take the below steps to ensure that states maintain a role as regulators in this emerging market: The FDA should define preemption terms in a way that…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: December 2021 Update for the Attorney General Community

On December 20, the U.S. reached 241.6 million persons (72.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 203.9 million persons (61.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Predatory and Unethical Practices in Substance Use Treatment, Part 1

The first training of this series addresses foundational concepts regarding substance use disorders, the treatment landscape, and relevant policy and legal considerations. Participants will also hear from people with lived experiences in navigating substance use treatment for themselves or loved ones including unethical, predatory, and fraudulent practices. The second training in this series, hosted on…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: November 2021 Update for the Attorney General Community

On November 30, the U.S. reached 232.8 million persons (70.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 196.8 million persons (59.3% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: October 2021 Update for the Attorney General Community

On October 22, the U.S. reached over 611.0 million total COVID-19 vaccine doses administered with 219.6 million persons (66.2% of the total U.S. population) having received at least one dose and 189.9 million persons (57.2% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine…

Read More →

COVID-19 and Its Impacts on Substance Use and Overdose

Provisional Centers for Disease Control & Prevention (CDC) data show that U.S. drug overdose deaths increased by 30% in 2020 from the prior year, reaching an all-time high. Increases in overdose deaths were reported for synthetic opioids (primarily fentanyl), natural or semi-synthetic opioids (e.g., prescription pain medications), psychostimulants (e.g., methamphetamine), and cocaine. In many ways,…

Read More →